CATHERINE BOLLARD
Inventor
Stats
- 0 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 9 US Applications Filed
- 3 Total Citation Count
- Dec 16, 2021 Most Recent Filing
- Mar 21, 2016 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CHILDREN'S NATIONAL MEDICAL CENTER | 1
| 2016
|
Inventor Addresses
| Address | Duration |
|---|---|
| Bathesda, MD, US | Feb 18, 21 - Feb 18, 21 |
| Bethesda, MD, US | May 26, 22 - Feb 18, 25 |
| Washington, DC, US | Mar 15, 18 - Jul 04, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07K: | PEPTIDES | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12227590 | 2025 | Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context | 0 |
| 12168046 | 2024 | Mycobacterial antigen compositions and methods of use | 0 |
| 2024/0216,507 | 2024 | SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING THEM | 0 |
| 2023/0036,213 | 2023 | T-CELL EPITOPES OF HUMAN PARAINFLUENZA VIRUS 3 FOR ADOPTIVE T-CELL IMMUNOTHERAPY | 0 |
| 2022/0185,909 | 2022 | METHODS AND COMPOSITION FOR A BINDING MOLECULE TARGETING CANCER CELLS EXPRESSING SSX2 PEPTIDE 41-49 IN HLA-A*0201 CONTEXT | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.